Nisa Investment Advisors
DYN icon

Nisa Investment Advisors’s Dyne Therapeutics DYN Stock Holding History

Nisa Investment Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.2K Buy
3,387
+415
+14% +$7.72K ﹤0.01% 1681
2026
Q1 		$53.9K Sell
2,972
-7,527
-72% -$130K ﹤0.01% 1635
2025
Q4 		$205K Buy
10,499
+9,550
+1,006% +$181K ﹤0.01% 1225
2025
Q3 		$12K Sell
949
-76
-7% -$867 ﹤0.01% 2213
2025
Q2 		$9.76K Sell
1,025
-475
-32% -$5.23K ﹤0.01% 2277
2025
Q1 		$15.7K Buy
1,500
+790
+111% +$11.3K ﹤0.01% 1978
2024
Q4 		$16.7K Sell
710
-59
-8% -$1.75K ﹤0.01% 1991
2024
Q3 		$27.6K Buy
769
+26
+3% +$1.03K ﹤0.01% 1807
2024
Q2 		$26.2K Buy
743
+669
+904% +$19.4K ﹤0.01% 1852
2024
Q1 		$2.1K Buy
+74
New +$1.67K ﹤0.01% 2226
2023
Q4 		– Sell
-35
Closed -$314 – 2672
2023
Q3 		$314 Sell
35
-10
-22% -$108 ﹤0.01% 2604
2023
Q2 		$506 Hold
45
– – ﹤0.01% 2557
2023
Q1 		$1K Hold
45
– – ﹤0.01% 2374
2022
Q4 		$1K Buy
+45
New +$521 ﹤0.01% 2422
2022
Q3 		– Sell
-347
Closed -$2K – 2595
2022
Q2 		$2K Sell
347
-14,000
-98% -$96.4K ﹤0.01% 2343
2022
Q1 		$138K Buy
14,347
+14,000
+4,035% +$119K ﹤0.01% 1508
2021
Q4 		$3K Sell
347
-477
-58% -$6.7K ﹤0.01% 2111
2021
Q3 		$13K Sell
824
-6,682
-89% -$118K ﹤0.01% 2171
2021
Q2 		$158K Hold
7,506
– – ﹤0.01% 1494
2021
Q1 		$117K Hold
7,506
– – ﹤0.01% 1681
2020
Q4 		$158K Buy
+7,506
New +$148K ﹤0.01% 1567

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nisa Investment Advisors's DYN Position: Q2 2026 in Review

Nisa Investment Advisors increased its Dyne Therapeutics (DYN) stake by 14% in Q2 2026, buying an estimated $7.72K and bringing the position to 3,387 shares worth $75.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Nisa Investment Advisors first reported a position in DYN in Q4 2020 and has held it in 21 quarters since. The position peaked at $205K in Q4 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Nisa Investment Advisors held 3,387 shares of Dyne Therapeutics worth $75.2K as of Q2 2026.
  • Nisa Investment Advisors bought 415 Dyne Therapeutics shares in Q2 2026, an estimated $7.72K.
  • Dyne Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1681 holding.
  • Nisa Investment Advisors first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Nisa Investment Advisors's Dyne Therapeutics position peaked at $205K in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.